E998: The Next Unicorns: Benchling CEO & Co-founder Sajith Wickramasekara is increasing efficiency for scientists with a cloud-based platform, gives insights on recent life-science innovations, ethics of gene therapy & defining the line between quackery & brilliance – E10 of 10-ep miniseries
This Week in Startups
00:00
Ethics and Innovations in Gene Therapy
This chapter examines the ethical challenges posed by CRISPR technology, particularly in the context of human embryo editing and the strong reactions from the scientific community. It highlights the advancements and complexities of gene therapy, exploring its potential for treating genetic disorders while emphasizing the need for regulatory oversight. The conversation further delves into the evolving perception of immunotherapy and the historical journey of cancer treatment, blending science with psychological factors impacting patient outcomes.
Transcript
Play full episode
